Showing results (1-10 of 185) with videos related to
Sort By:
Pageof 19
Advances in Experimental Medicine and Biology|January 28, 2026
Structure-Function Relationships of K<sub>2P</sub> ChannelsJulian A Schreiber, Guiscard SeebohmCellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|May 27, 2021
Beyond Hot and Spicy: TRPV Channels and their Pharmacological ModulationGuiscard Seebohm, Julian A SchreiberHandbook of Experimental Pharmacology|July 11, 2021
Cardiac K<sup>+</sup> Channels and ChannelopathiesJulian A Schreiber, Guiscard SeebohmCellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|November 25, 2022
The Special One: Architecture, Physiology and Pharmacology of the TRESK ChannelJulian A Schreiber, Martina Düfer, Guiscard SeebohmEuropean Journal of Medicinal Chemistry|November 9, 2020
Synthesis of GluN2A-selective NMDA receptor antagonists with an electron-rich aromatic B-ringRemya Rajan, Dirk Schepmann, Julian A Schreiber, et al.Journal of Medicinal Chemistry|December 30, 2025
Stereoselective Synthesis of Conformationally Restricted γ- and β-Amino Alcohols as GluN2B Subtype-Selective NMDA Receptor AntagonistsMarvin Korff, Gunnar Goerges, Judith Schmidt, et al.Archiv Der Pharmazie|May 23, 2022
Phenol-Benzoxazolone bioisosteres: Synthesis and biological evaluation of tricyclic GluN2B-selective N-methyl- d-aspartate receptor antagonistsAlexander Markus, Julian A Schreiber, Gunnar Goerges, et al.Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|March 3, 2021
Deconstruction - Reconstruction: Analysis of the Crucial Structural Elements of GluN2B-Selective, Negative Allosteric NMDA Receptor Modulators with 3-Benzazepine ScaffoldNadine Ritter, Marvin Korff, Alexander Markus, et al.European Journal of Medicinal Chemistry|February 22, 2017
Systematic variation of the benzenesulfonamide part of the GluN2A selective NMDA receptor antagonist TCN-201Sebastian L Müller, Julian A Schreiber, Dirk Schepmann, et al.Molecular Pharmacology|December 21, 2004
Activators of cation channels: potential in treatment of channelopathiesGuiscard SeebohmPageof 19